Kati Kämpjärvi

1.8k total citations
20 papers, 1.0k citations indexed

About

Kati Kämpjärvi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Kati Kämpjärvi has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Obstetrics and Gynecology, 9 papers in Reproductive Medicine and 6 papers in Molecular Biology. Recurrent topics in Kati Kämpjärvi's work include Uterine Myomas and Treatments (10 papers), Endometriosis Research and Treatment (6 papers) and Ovarian cancer diagnosis and treatment (4 papers). Kati Kämpjärvi is often cited by papers focused on Uterine Myomas and Treatments (10 papers), Endometriosis Research and Treatment (6 papers) and Ovarian cancer diagnosis and treatment (4 papers). Kati Kämpjärvi collaborates with scholars based in Finland, United States and Sweden. Kati Kämpjärvi's co-authors include Pia Vahteristo, Netta Mäkinen, Ralf Bützow, Lauri A. Aaltonen, Jari Sjöberg, Hanna-Riikka Heinonen, Miika Mehine, Esa Pitkänen, Outi Kilpivaara and Eevi Kaasinen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Cancer Research.

In The Last Decade

Kati Kämpjärvi

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Kati Kämpjärvi

Since Specialization

Citations

This map shows the geographic impact of Kati Kämpjärvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kati Kämpjärvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kati Kämpjärvi more than expected).

Fields of papers citing papers by Kati Kämpjärvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kati Kämpjärvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kati Kämpjärvi. The network helps show where Kati Kämpjärvi may publish in the future.

Co-authorship network of co-authors of Kati Kämpjärvi

This figure shows the co-authorship network connecting the top 25 collaborators of Kati Kämpjärvi. A scholar is included among the top collaborators of Kati Kämpjärvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kati Kämpjärvi. Kati Kämpjärvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted sequencing and in vitro splice assays shed light on ABCA4-associated retinopathies missing heritability 2023 ·Human Genetics and Genomics Advances ·(unknown), Mubeen Khan, (unknown), Ketan Mishra, Laura Whelan, Stéphanie S. Cornelis, Carel B. Hoyng, Kati Kämpjärvi, Caroline C. W. Klaver, Petra Lišková, Heidi Stöhr, Bernhard H. F. Weber, Sandro Banfi, G. Jane Farrar, Dror Sharon, Jana Zernant, Rando Allikmets, Claire‐Marie Dhaenens, Frans P.M. Cremers	7
2	Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology 2021 ·Acta Obstetricia Et Gynecologica Scandinavica ·Outi Uimari, Anne Ahtikoski, Kati Kämpjärvi, Ralf Bützow, Ilkka Y. Järvelä, Markku Ryynänen, Lauri A. Aaltonen, Pia Vahteristo, Outi Kuismin	11
3	Prevalence and genetic characteristics of RPE65-associated retinal disease 2019 ·Investigative Ophthalmology & Visual Science ·Tero‐Pekka Alastalo, Kati Kämpjärvi, Lucia Guidugli, Johanna Känsäkoski, (unknown), (unknown), Laura Sarantaus, Pertteli Salmenperä, Samuel Myllykangas, Eeva-Marja Sankila, Juha Koskenvuo, Sari Tuupanen	3
4	A whole exome sequencing-based panel assay with boosted clinical content generates a high diagnostic yield in patients with inherited eye diseases 2019 ·Investigative Ophthalmology & Visual Science ·Kati Kämpjärvi, (unknown), Miika Mehine, Johanna Känsäkoski, Laura Sarantaus, (unknown), Jennifer Schleit, (unknown), Mikko Muona, Samuel Myllykangas, Tero‐Pekka Alastalo, Juha Koskenvuo, Jussi Paananen, Sari Tuupanen	1
5	Characterization of copy number variants (CNVs) identified by genetic testing of inherited retinal disorders 2019 ·Lucia Guidugli, Miika Mehine, Sari Tuupanen, Kati Kämpjärvi, (unknown), Johanna Känsäkoski, Miko Valori, (unknown), Mikko Muona, Eeva-Marja Sankila, Samuel Myllykangas, Juha Koskenvuo, Tero‐Pekka Alastalo	0
6	Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors 2017 ·Molecular Cancer ·Netta Mäkinen, Kati Kämpjärvi, Norma Frizzell, Ralf Bützow, Pia Vahteristo	75
7	Somatic MED12 Nonsense Mutation Escapes mRNA Decay and Reveals a Motif Required for Nuclear Entry 2017 ·Human Mutation ·Tuomas Heikkinen, Kati Kämpjärvi, Salla Keskitalo, Pernilla von Nandelstadh, Xiaonan Liu, Ville Rantanen, Esa Pitkänen, Matias Kinnunen, Heikki Kuusanmäki, Mika Kontro, Mikko Turunen, Netta Mäkinen, Jussi Taipale, Caroline A. Heckman, Kaisa Lehti, Satu Mustjoki, Markku Varjosalo, Pia Vahteristo	12
8	Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers 2016 ·Proceedings of the National Academy of Sciences ·Miika Mehine, Eevi Kaasinen, Hanna-Riikka Heinonen, Netta Mäkinen, Kati Kämpjärvi, Nanna Sarvilinna, Mervi Aavikko, Anna Vähärautio, Annukka Pasanen, Ralf Bützow, Oskari Heikinheimo, Jari Sjöberg, Esa Pitkänen, Pia Vahteristo, Lauri A. Aaltonen	157
9	MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas 2016 ·British Journal of Cancer ·Kati Kämpjärvi, Netta Mäkinen, Miika Mehine, (unknown), Outi Uimari, Esa Pitkänen, Hanna-Riikka Heinonen, Tuomas Heikkinen, Jaana Tolvanen, Anne Ahtikoski, Norma Frizzell, Nanna Sarvilinna, Jari Sjöberg, Ralf Bützow, Lauri A. Aaltonen, Pia Vahteristo	36
10	Abstract 4435: Genome-scale DNA methylation changes delineate uterine leiomyoma subgroups 2016 ·Cancer Research ·Eevi Kaasinen, Amjad Alkodsi, Miika Mehine, Hanna-Riikka Heinonen, Netta Mäkinen, Mervi Aavikko, Kati Kämpjärvi, Minna Taipale, Pia Vahteristo, Rainer Lehtonen, Lauri A. Aaltonen	1
11	Abstract 1169: Somatic MED12 mutations in hematological malignancies 2016 ·Cancer Research ·Tuomas Heikkinen, Kati Kämpjärvi, Sirpa Leppä, Peter Hokland, Heikki Kuusanmäki, Satu Mustjoki, Marjatta Sinisalo, Caroline A. Heckman, Mika Kontro, Pia Vahteristo	0
12	Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia 2014 ·Oncotarget ·Kati Kämpjärvi, Tiina M. Järvinen, Tuomas Heikkinen, Amy S. Ruppert, Leigha Senter, (unknown), Olli Dufva, Mika Kontro, Laura Z. Rassenti, Erin Hertlein, Thomas J. Kipps, Kimmo Porkka, John C. Byrd, Albert de la Chapelle, Pia Vahteristo	35
13	MED12 mutation frequency in unselected sporadic uterine leiomyomas 2014 ·Fertility and Sterility ·Hanna-Riikka Heinonen, Nanna Sarvilinna, Jari Sjöberg, Kati Kämpjärvi, Esa Pitkänen, Pia Vahteristo, Netta Mäkinen, Lauri A. Aaltonen	58
14	Mutations in Exon 1 Highlight the Role ofMED12in Uterine Leiomyomas 2014 ·Human Mutation ·Kati Kämpjärvi, (unknown), Miika Mehine, Nam Hee Kim, Alison D. Clark, Ralf Bützow, Tom Böhling, Jan Böhm, Jukka‐Pekka Mecklin, Heikki Järvinen, Ian Tomlinson, Zephne M. van der Spuy, Jari Sjöberg, Thomas G. Boyer, Pia Vahteristo	59
15	Uterine Leiomyoma-Linked MED12 Mutations Disrupt Mediator-Associated CDK Activity 2014 ·Cell Reports ·Mikko Turunen, Jason M. Spaeth, Salla Keskitalo, (unknown), Teemu Kivioja, Alison D. Clark, Netta Mäkinen, (unknown), Kimmo Palin, (unknown), Anna Vähärautio, Mervi Aavikko, Kati Kämpjärvi, Pia Vahteristo, Chongwoo A. Kim, Lauri A. Aaltonen, Markku Varjosalo, Jussi Taipale, Thomas G. Boyer	123
16	MED12 exon 2 mutations in histopathological uterine leiomyoma variants 2013 ·European Journal of Human Genetics ·Netta Mäkinen, Pia Vahteristo, Kati Kämpjärvi, Johanna Arola, Ralf Bützow, Lauri A. Aaltonen	62
17	Characterization of Uterine Leiomyomas by Whole-Genome Sequencing 2013 ·New England Journal of Medicine ·Miika Mehine, Eevi Kaasinen, Netta Mäkinen, Riku Katainen, Kati Kämpjärvi, Esa Pitkänen, Hanna-Riikka Heinonen, Ralf Bützow, Outi Kilpivaara, Anna Kuosmanen, Heikki Ristolainen, Massimiliano Gentile, Jari Sjöberg, Pia Vahteristo, Lauri A. Aaltonen	252
18	Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer 2012 ·British Journal of Cancer ·Kati Kämpjärvi, Netta Mäkinen, Outi Kilpivaara, Johanna Arola, Hanna-Riikka Heinonen, Jan Böhm, Omar Abdel‐Wahab, Heli Lehtonen, Liisa M. Pelttari, Miika Mehine, Heinrich Schrewe, Heli Nevanlinna, Ross L. Levine, Peter Hokland, Tom Böhling, Jukka‐Pekka Mecklin, Ralf Bützow, Lauri A. Aaltonen, Pia Vahteristo	87
19	Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications 2011 ·Breast Cancer Research ·Taru Muranen, Dario Greco, Rainer Fagerholm, Outi Kilpivaara, Kati Kämpjärvi, Kristiina Aittomäki, Carl Blomqvist, Päivi Heikkilä, Åke Borg, Heli Nevanlinna	47
20	Breast tumors from CHEK2 1100delC mutation carriers: genomic landscape and clinical implications 2011 ·Breast Cancer Research ·Taru Muranen, Dario Greco, Rainer Fagerholm, Outi Kilpivaara, Kati Kämpjärvi, Kristiina Aittomäki, Carl Blomqvist, Päivi Heikkilä, Åke Borg, Heli Nevanlinna	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact